Exosomes-EV-based Therapeutics Summit

Overview

SelectBIO Exosomes-Extracellular Vesicles (EVs)-based Therapeutics Summit 2019 focuses on the emerging field of deploying Exosomes as diagnostics and the engineering of exosomes and extracellular vesicles as a delivery tool for therapeutics moieties.

The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with exquisite targeting ability and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.

This summit explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.

This summit is co-located and concurrent with the SelectBIO Circulating Biomarkers, Exosomes and Liquid Biopsies Europe 2019 Conference providing a 360^o view of the field of exosomes and other circulating biomarker classes from biomarker/diagnostic potential to therapeutics and drug delivery opportunities in the future.

Information and Local Registration Facilities for this Conference are Also Available In:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)